CAPRICOR THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Basic Shares Outstanding (Weighted Average) of 57.93 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 57.93M shares, a 26.73% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 57.43M shares, a 25.85% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 48.85M shares, a 9.59% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 45.72M shares, a 38.16% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 46.48M shares, a 31.97% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 35.22M shares, a 31.52% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 26.78M shares, a 9.06% increase from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 24.55M shares, a 6.34% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 57.93M shares 10-Q · filed 2026-08-14 | 57.68M shares 10-Q · filed 2026-08-14 | 54.74M shares derived: average of 3 quarters · filed 2026-08-14 | 52.48M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 57.43M shares 10-Q · filed 2026-05-13 | 53.14M shares derived: average of 2 quarters · filed 2026-05-13 | 50.67M shares derived: average of 3 quarters · filed 2026-05-13 | 49.43M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | 48.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 47.28M shares derived: average of 2 quarters · filed 2026-03-17 | 46.76M shares derived: average of 3 quarters · filed 2026-08-14 | 46.48M shares 10-K · filed 2026-03-17 | |
| 2025-09-30 | 45.72M shares 10-Q · filed 2025-11-10 | 45.71M shares derived: average of 2 quarters · filed 2026-08-14 | 45.69M shares 10-Q · filed 2025-11-10 | 45.41M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | 45.71M shares 10-Q · filed 2026-08-14 | 45.67M shares 10-Q · filed 2026-08-14 | 45.31M shares derived: average of 3 quarters · filed 2026-08-14 | 42.25M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | 45.64M shares 10-Q · filed 2026-05-13 | 45.11M shares derived: average of 2 quarters · filed 2026-05-13 | 41.10M shares derived: average of 3 quarters · filed 2026-05-13 | 38.79M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 44.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 38.83M shares derived: average of 2 quarters · filed 2026-03-17 | 36.50M shares derived: average of 3 quarters · filed 2026-03-17 | 35.22M shares 10-K · filed 2026-03-17 | |
| 2024-09-30 | 33.09M shares 10-Q · filed 2025-11-10 | 32.47M shares derived: average of 2 quarters · filed 2025-11-10 | 32.10M shares 10-Q · filed 2025-11-10 | 31.75M shares derived: average of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | 31.84M shares 10-Q · filed 2025-08-11 | 31.60M shares 10-Q · filed 2025-08-11 | 31.30M shares derived: average of 3 quarters · filed 2025-08-11 | 29.93M shares derived: average of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | 31.35M shares 10-Q · filed 2025-05-14 | 31.03M shares derived: average of 2 quarters · filed 2025-05-14 | 29.29M shares derived: average of 3 quarters · filed 2025-05-14 | 28.30M shares derived: average of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | 30.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 28.26M shares derived: average of 2 quarters · filed 2025-03-26 | 27.29M shares derived: average of 3 quarters · filed 2025-03-26 | 26.78M shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 25.82M shares 10-Q · filed 2024-11-14 | 25.58M shares derived: average of 2 quarters · filed 2024-11-14 | 25.47M shares 10-Q · filed 2024-11-14 | 25.39M shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | 25.34M shares 10-Q · filed 2024-08-08 | 25.29M shares 10-Q · filed 2024-08-08 | 25.25M shares derived: average of 3 quarters · filed 2024-08-08 | 25.05M shares derived: average of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | 25.25M shares 10-Q · filed 2024-05-14 | 25.21M shares derived: average of 2 quarters · filed 2024-05-14 | 24.95M shares derived: average of 3 quarters · filed 2024-05-14 | 24.79M shares derived: average of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | 25.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 24.80M shares derived: average of 2 quarters · filed 2024-03-11 | 24.64M shares derived: average of 3 quarters · filed 2024-03-11 | 24.55M shares 10-K · filed 2024-03-11 | |
| 2022-09-30 | 24.43M shares 10-Q · filed 2023-11-14 | 24.38M shares derived: average of 2 quarters · filed 2023-11-14 | 24.35M shares 10-Q · filed 2023-11-14 | 24.30M shares derived: average of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 24.32M shares 10-Q · filed 2023-08-08 | 24.30M shares 10-Q · filed 2023-08-08 | 24.26M shares derived: average of 3 quarters · filed 2023-08-08 | 23.97M shares derived: average of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | 24.28M shares 10-Q · filed 2023-05-12 | 24.22M shares derived: average of 2 quarters · filed 2023-05-12 | 23.85M shares derived: average of 3 quarters · filed 2023-05-12 | 23.60M shares derived: average of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | 24.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | 23.63M shares derived: average of 2 quarters · filed 2023-03-17 | 23.37M shares derived: average of 3 quarters · filed 2023-03-17 | 23.09M shares 10-K · filed 2023-03-17 | |
| 2021-09-30 | 23.10M shares 10-Q · filed 2022-11-10 | 22.98M shares derived: average of 2 quarters · filed 2022-11-10 | 22.73M shares 10-Q · filed 2022-11-10 | 22.15M shares derived: average of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | 22.86M shares 10-Q · filed 2022-08-12 | 22.55M shares 10-Q · filed 2022-08-12 | 21.83M shares derived: average of 3 quarters · filed 2022-08-12 | 21.33M shares derived: average of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | 22.23M shares 10-Q · filed 2022-05-11 | 21.32M shares derived: average of 2 quarters · filed 2022-05-11 | 20.81M shares derived: average of 3 quarters · filed 2022-05-11 | 19.39M shares derived: average of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | 20.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 20.11M shares derived: average of 2 quarters · filed 2022-03-11 | 18.45M shares derived: average of 3 quarters · filed 2022-03-11 | 15.57M shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 19.80M shares 10-Q · filed 2021-11-12 | 17.47M shares derived: average of 2 quarters · filed 2021-11-12 | 13.96M shares 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 15.13M shares 10-Q · filed 2021-08-13 | 11.00M shares 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | 3.71M shares 10-K · filed 2021-03-15 | ||||
| 2018-12-31 | 2.94M shares 10-K · filed 2020-03-27 | 29.41M shares 10-K · filed 2019-03-29 | |||
| 2017-12-31 | 23.19M shares 10-K · filed 2019-03-29 | ||||
| 2016-12-31 | 18.55M shares 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |